The simple mechanism used by potentially virulent bacteria to fend off antibiotics, providing new insights into how germs adapt and behave, was identified in detail by physicists at McMaster University for the first time.
The findings, published in the journal Nature Communications Biology, could have implications in the global battle against antibiotic resistance, enabling the design of better, more effective drugs to fight infection.
Antibiotics
Antibiotics are among the most used and abused medications. This article explains some general features about antibiotics.
Advertisement
‘Physicists concluded that when a bacterium has become resistant, its cell membrane will be more rigid and the charge is weak, making it much less attractive to the drug and harder to penetrate.’
Read More..
Tweet it Now
Read More..
"There are many, many bacteria out there, and so many antibiotics, but by proposing a basic model that applies to many of them, we can have a much better understanding on how to tackle and predict resistance better," says Maikel Rheinstädter, a professor in the Department of Physics and Astronomy at McMaster and lead author of the study.
Researchers examined how the membranes of bacteria interacted with the antibiotic polymyxin B (PmB), which is commonly used to treat urinary tract infections, meningitis, blood and eye infections.
They concentrated on PmB because it was once considered the strongest drug of its kind, a last line of defense for physicians when nothing else worked. That failsafe status came into question in 2016, when Chinese scientists discovered a gene that allowed bacteria to become resistant even to polymyxins.
"We wanted to find out how this bacteria, specifically, was stopping this drug in this particular case," says Adree Khondker, a health sciences undergraduate student and first author on the study. "If we can understand that, we can design better antibiotics."
Employing techniques typically used by physicists for materials research, the team used highly specialized equipment to peer deep into the bacterial membrane, capturing images with a resolution so fine they could view individual molecules at approximately 1/1,000,000th the width of a strand of human hair.
"If you take the bacterial cell and add this drug, holes will form in the wall, acting like a hole-puncher, and killing the cell. But there was much debate on how these holes were formed in the first place." explains Khondker.
When these antibiotics are working properly, researchers know the basic laws of physics apply: because the drug is positively charged it is attracted to the negatively charged bacteria. At the same time, the bacterial membrane is employing a repulsive force as it attempts to repel the drug.
Through imaging and simulations, researchers pinpointed which part of the antibiotic enters the membrane, where it enters and how deeply it penetrates. They simulated these processes on microsecond timescales with high-end gaming computers in their lab.
They determined that when a bacterium has become resistant, its membrane is more rigid and the charge is weaker, making it much less attractive to the drug and harder to penetrate. "For the drug, it's like going from cutting Jello to cutting through rock." Khondker says.
"There has been a lot of speculation about this mechanism," says Rheinstädter. "But for the first time we can prove the membrane is more rigid and the process is slowed."
The World Health Organization (WHO) considers the issue of antibacterial resistance a top global threat to public health, threatening our ability to treat common infectious illnesses, resulting in prolonged illness, disability and death. An estimated 70,000 people worldwide die every year from drug-resistant strains of bacterial infections, HIV/AIDS, tuberculosis and malaria.
Experts have warned that by 2050, the annual death toll will soar to 10 million worldwide.
Source: Eurekalert
Advertisement
They concentrated on PmB because it was once considered the strongest drug of its kind, a last line of defense for physicians when nothing else worked. That failsafe status came into question in 2016, when Chinese scientists discovered a gene that allowed bacteria to become resistant even to polymyxins.
"We wanted to find out how this bacteria, specifically, was stopping this drug in this particular case," says Adree Khondker, a health sciences undergraduate student and first author on the study. "If we can understand that, we can design better antibiotics."
Employing techniques typically used by physicists for materials research, the team used highly specialized equipment to peer deep into the bacterial membrane, capturing images with a resolution so fine they could view individual molecules at approximately 1/1,000,000th the width of a strand of human hair.
"If you take the bacterial cell and add this drug, holes will form in the wall, acting like a hole-puncher, and killing the cell. But there was much debate on how these holes were formed in the first place." explains Khondker.
When these antibiotics are working properly, researchers know the basic laws of physics apply: because the drug is positively charged it is attracted to the negatively charged bacteria. At the same time, the bacterial membrane is employing a repulsive force as it attempts to repel the drug.
Through imaging and simulations, researchers pinpointed which part of the antibiotic enters the membrane, where it enters and how deeply it penetrates. They simulated these processes on microsecond timescales with high-end gaming computers in their lab.
They determined that when a bacterium has become resistant, its membrane is more rigid and the charge is weaker, making it much less attractive to the drug and harder to penetrate. "For the drug, it's like going from cutting Jello to cutting through rock." Khondker says.
"There has been a lot of speculation about this mechanism," says Rheinstädter. "But for the first time we can prove the membrane is more rigid and the process is slowed."
The World Health Organization (WHO) considers the issue of antibacterial resistance a top global threat to public health, threatening our ability to treat common infectious illnesses, resulting in prolonged illness, disability and death. An estimated 70,000 people worldwide die every year from drug-resistant strains of bacterial infections, HIV/AIDS, tuberculosis and malaria.
Experts have warned that by 2050, the annual death toll will soar to 10 million worldwide.
Source: Eurekalert
Advertisement
Advertisement
|
Advertisement
Recommended Reading
Latest Drug News
The new drug target sheds insights into strategies to fight drug-resistant S. pneumoniae, stated research.
The effectiveness of adding fludrocortisone to hydrocortisone vs hydrocortisone alone among patients with septic shock was analyzed using target trial emulation.
Safety and effectiveness of commonly used painkillers (analgesics) for short-term relief of low back pain remain uncertain.
India's First Urinary Incontinence Drug Fesobig may offer Affordable treatment for Overactive Bladder (OAB), a widely prevalent problem among Indian men and women.
Oral anticoagulant drugs, particularly Rivaroxaban presented superior efficacy and safety than warfarin in atrial fibrillation patients with chronic kidney disease.